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Awakening dormant mRNAs
The translational control of many maternal mRNAs in oocytes and early
embryos relies on changes in poly(A) tail length; the factors controlling
poly(A) tail length are being identified in a range of species.
Gene expression can in principle be controlled at any of
the steps on the pathway from a gene to a functional pro-
tein. Several of these steps occur after a mature mRNA
is generated in the nucleus: they include transit of the
mRNA from the nucleus, its translation into protein and
its eventual degradation. These steps frequently involve
the mRNA's 3' untranslated region (UTR), the sequence
of which is not subject to such stringent constraints as
either the protein-coding region or the 5' UTR, where
the translational machinery assembles. Indeed, a growing
body of information, from a wide range of biological sys-
tems, indicates that the 3' UTRs of mRNAs play remark-
ably varied and intriguing roles in the control of gene
expression (Fig. 1; see [1] for a review). In particular,
control of the translation of specific mRNAs has been
shown to involve cis-acting regulatory sequences located
in their 3' UTRs; in oocytes from many different animal
species, this control operates through cytosolic deadeny-
lation and readenylation of the mRNAs' poly(A) tails.
Maternal gene products are essential to the early stages of
development in all metazoans. During their growth phase,
oocytes accumulate macromolecules that will not be
required before the last stages of oogenesis - the com-
pletion of meiosis - and the initiation of development.
For instance, certain oocyte mRNAs remain stable and
untranslated for very long time periods, until they are re-
cruited for translation at specific times either during mei-
otic maturation or after fertilization. Oocytes thus provide
a powerful experimental system in which to explore the
molecular mechanisms of translational control.
The concept of dormant maternal mRNAs was first
established in sea urchins, on the basis of experiments
showing that fertilization-induced changes in protein syn-
thesis could occur even in the absence of transcription
[2]. The mechanisms responsible for translational control
in oocytes have been studied in a variety of animal spe-
cies. An investigation of Spisula oocytes revealed that
fertilization triggers changes in the length of the poly(A)
tail of different mRNAs; these changes were found to
correlate with changes in the translational activity of the
mRNAs, as measured by their presence on polysomes
[3]. These early observations could not, however, estab-
lish whether the changes in poly(A) tail length were
responsible for translational activation or repression, or
merely coincidental with it.
In the last few years, considerable progress has been made
in elucidating the features of the mRNA molecules that
determine their translational control in oocytes. Work on
Xenopus laevis and mouse oocytes (see [4,5] for reviews)
has established that the length of the poly(A) tail - or, in
two cases, the actual process of poly(A) elongation - is
directly responsible for mRNA translation. Dormant
mRNAs have a short poly(A) tail, and mRNAs that are
silenced during oocyte growth, meiotic maturation or
after fertilization undergo a shortening of their poly(A)
tail; mRNAs that are recruited for translation undergo a
lengthening of the poly(A) tail, and a long poly(A) tail is
necessary and sufficient for translation.
The 3' UTRs of maternal mRNAs have been identified
as critical in the control of their poly(A) tail length. The
most direct evidence for this comes from experiments in
which the 3' UTRs of endogenous mRNAs in oocytes
were cleaved off following injection of antisense RNA or
DNA fragments, presumably through the action of du-
plex-targeted endoribonuclease(s); amputation of their 3'
UTRs was found selectively to prevent polyadenylation
of maternal RNAs [6,7]. Furthermore, prosthetic re-
placement of the 3' UTR by injection of an RNA frag-
ment capable of base-pairing to the remaining mRNA
stump rescues in trans the control of polyadenylation [7].
A common feature of the 3' UTR control elements is
that they are U-rich. As they determine whether a given
mRNA undergoes deadenylation and/or readenylation at
specific times, these sequences have been designated
cytoplasmic polyadenylation elements (CPEs) or adenyla-
tion control elements (ACEs). A number of different
mRNAs of Xenopus- G10, B4, Cll, C12, c-mos, cyclins
Al, B1 and B2, Eg2 and cdk2 - and mouse - tPA,
OM-1, OM-2, HPRT and c-mos - have been shown to
follow the mode of translational control outlined here.
Interestingly, the timing of deadenylation and of poly-
adenylation, and therefore of silencing or translation, of
different mRNAs varies, perhaps depending on the pre-
cise nature and position of their CPEs or other sequences
present in their 3' UTRs.
The first studies aimed at identifying CPEs were carried
out with mRNAs undergoing polyadenylation and trans-
lational activation during meiotic maturation. In both
Xenopus and mouse oocytes, two cis elements are critical
for cytoplasmic poly(A) addition: the hexanucleotide
AAUAAA that is also involved in the cleavage and nuclear
polyadenylation of primary transcripts, and the CPE
itself. The latter element is U-rich, typically containing
UUUUUAU or AUUUUAAU, or a similar sequence.
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Fig. 1. Multiple roles for mRNA 3' UTRs. Sequence elements in the 3' UTR of different mRNAs are involved in controlling aspects of the
fate of the mRNA itself, such as its subcellular localization (illustrated by the distribution of bicoid mRNA in Drosophila eggs), its asso-
ciation with polysomes (and thereby its translation), its state of polyadenylation (which controls its translation in oocytes and eggs) and
its rate of decay The 3' UTR elements can control the different fates of mRNA either positively - for example, polyadenylation induces
recruitment on polysomes - or negatively - for example, UA-rich elements arrest translation of injected mRNAs in Xenopus eggs.
More recently, CPEs have been identified that act to
promote polyadenylation and translation of maternal
mRNAs after fertilization in Xenopus embryos [8]. For
one maternal mRNA (C12), the CPE consists of at least
12 Us, for the other (Cll) it consists of 18 Us, and there
is a difference in the timing of the polyadenylation of
these two mRNAs. Furthermore, in both cases the dis-
tance between the CPE and the AAUAAA affects the pre-
cise timing and extent of polyadenylation. In both cases,
also, there are additional, apparently unrelated, sequences
that are responsible for preventing the premature poly-
adenylation of the mRNAs in meiotically maturing
oocytes (that is, before fertilization).
Whereas translational activation of dormant oocyte and
embryo mRNAs is achieved by a mechanism that in-
volves poly(A) tail elongation, the silencing of mRNAs
appears to be accompanied by deadenylation. In growing
mouse primary oocytes, for instance, newly-transcribed
tissue-type plasminogen activator (tPA) RNA receives a
long poly(A) tail, which is subsequently trimmed to
30-40 nucleotides. This process is sequence-specific, in
that it requires the same CPE sequence that is involved in
readenylation of tPA mRNA during meiotic maturation
[9]. Following germinal vesicle breakdown (GVBD) in
Xenopus oocytes, a number of mRNAs undergo de-
adenylation and leave the translated pool. This process,
which does not appear to be sequence-specific, and is
thus referred to as the default pathway of deadenylation,
accounts for the large decrease in total poly(A) content
that occurs during maturation.
B4, cdk2 and Eg2 mRNAs, which are polyadenylated
during meiotic maturation of Xenopus oocytes, have dif-
ferent fates following fertilization [10,11]: while B4
maintains its poly(A) tail, cdk2 and Eg2 mRNAs are
deadenylated because of the presence of 3' UTR se-
quences that are distinct from the CPE. Disruption of
the deadenylation element allows polyadenylation of non-
adenylated Eg2 mRNA injected into embryos. Thus,
multiple cis-acting sequences and regulatory factors ap-
pear to be involved in a complex system of translational
regulations operating to allow completion of oogenesis
and early development. The common theme of this stem
is that it relies on control of the poly(A) tail length of
maternal mRNAs, with specificity determinants residing
in the 3' UTRs.
That a similar type of control operates in eggs and
embryos from clams to mammals attests to its evolution-
ary success, a view that receives support from recent ob-
servations on the fruitfly Drosophila. Indeed, it has now
been reported that this mode of translational control is
involved in aspects of Drosophila embryonic pattern for-
mation [12]. The four maternal mRNAs that specify
broad regions of the early embryo - bicoid (anterior),
nanos (posterior), Toll (dorso-ventral) and torso (terminal)
- are activated for translation during early embryogen-
esis. For three of these (bicoid, Toll and torso), polyadenyla-
tion occurs concomitantly with translational activation.
To explore directly the role of polyadenylation in bicoid
mRNA translation, an experimental system was developed
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in which injected bicoid transcripts were analyzed for
their capacity to rescue embryos homozygous for a mu-
tation that prevents production of functional Bicoid pro-
tein [12]. Whereas wild-type bicoid mRNA underwent
cytoplasmic polyadenylation and fully rescued mutant
embryos, bicoid transcripts lacking part of the 3' UTR
were not significantly polyadenylated and were ineffec-
tive in rescue. Addition of a poly(A) tail of approximately
175 nucleotides partially restored the rescuing ability of
the 3' UTR-deleted mRNA. Thus, sequences in the
3' UTR of bicoid mRNA regulate its cytoplasmic poly-
adenylation, and a poly(A) tail of sufficient length
is required for translation; the relevant bicoid 3' UTR se-
quences have not yet been characterized. Because certain
Drosophila female-sterile phenotypes may be caused by
mutations in genes involved in this regulatory pathway, it
is likely that this newly described experimental system
will contribute to rapid progress in elucidating the
mechanism of poly(A)-mediated translational control.
One critical next step in the elucidation of this mecha-
nism of translational control is the identification of the
specificity factors that recognize the cis-acting elements
in the 3' UTRs, in particular the CPEs. Ultraviolet (UV)
light cross-linking experiments have identified a number
of different proteins in Xenopus oocyte lysates that appear
to interact with CPEs. One of these, designated as CPEB
(for CPE-binding protein), has recently been purified
by single-step RNA affinity chromatography, and its
cDNA has been cloned [13]. This 62 kD protein con-
tains two RNA recognition motifs; within this region, it
is 62 % identical to 'Orb', an oocyte-specific RNA-
binding protein from Drosophila. Immunodepletion and
reconstitution experiments have provided very strong
evidence that CPEB has a critical role in the cytoplasmic
polyadenylation of mRNAs.
Interestingly, CPEB does not bind to all mRNAs that
contain a CPE-type sequence. Additional proteins, of
36, 45 and 82 kD, that can be UV cross-linked to differ-
ent CPE-containing transcripts have been observed in
unfertilized Xenopus eggs [8,14]; proteins of 53-55 kD
that appear specific for an mRNA that undergoes de-
adenylation in Xenopus embryos have also been observed
[15]. The characterization of CPEB is an important
achievement that opens the way to future studies of
other proteins involved in 3' UTR-mediated transla-
tional control. It should be noted that some of these pro-
teins may themselves be the translational products of
'upstream' mRNAs, and therefore that the completion
of oogenesis and early embryogenesis might require a
cascade of translational activation.
The identification of proteins that interact with the 3'
UTRs of maternal mRNAs should advance our under-
standing of how poly(A) metabolism is controlled. In this
context, the observation that CPEB is phosphorylated
during oocyte maturation, perhaps by p34cdc2 - the cat-
alytic component of maturation-promoting factor (MPF)
- and that this post-translational modification appears
necessary for polyadenylation of the target mRNAs, pro-
vides an interesting link with the kinase cascades that
regulate progression through the cell cycle [16]. As to the
mechanism of polyadenylation itself, there is good in vitro
evidence to suggest that factors also implicated in nuclear
polyadenylation (in particular 'cleavage and polyadenyla-
tion specificity factor', CPSF, and poly(A) polymerase)
may be involved. The recent identification [17] of a
Xenopus poly(A) polymerase that exists in different forms
depending upon its nuclear or cytoplasmic localization,
and that undergoes dynamic changes during oocyte mat-
uration and early development, provides an additional
tool with which to unravel the mechanism of cytoplas-
mic polyadenylation. Surprisingly perhaps, CPSF and
poly(A) polymerase can stimulate polyadenylation in a
CPE-dependent fashion [18]. Different CPEBs might
then be viewed as specificity factors that help recruit
CPSF to different mRNAs at different times, for instance
during meiotic maturation or after fertilization.
Less is known about the deadenylation reactions that
silence mRNAs in primary oocytes, maturing oocytes
and embryos. The system responsible for the default
deadenylation of mRNAs following GVBD appears to
involve nuclear and cytoplasmic elements, which are
kept separate until GVBD [5]. The possible relationship
between the poly(A)-specific nucleases characterized in
human cells [19] and in yeast [20] and the oocyte
enzyme(s) remains to be explored. In any event, it will be
necessary to account for the differences in the timing
and extent of deadenylation of different transcripts. In
primary mouse oocytes, for instance, CPE-dependent
deadenylation stops when a poly(A) tail length of 30-40
nucleotides is reached, an observation suggestive of a role
for a poly(A)-binding protein (PABP) in this process,
whereas in maturing mouse oocytes the default deadeny-
lation reaction appears to remove essentially the entire
poly(A) tail [9]. Finally, it is likely that the length of the
poly(A) tails may reflect a dynamic equilibrium between
addition and removal of A nucleotides.
The determining role of 3' UTRs and poly(A) tails in
the translational control of maternal mRNAs is now
well established. In addition to the questions raised
above however, there are, at least two further issues that
need to be investigated. First, how do changes at the 3'
end of mRNA molecules so dramatically affect transla-
tion? In this respect it is worthwhile recalling that yeast
mutants lacking PABP are severely defective in transla-
tion initiation, and that there is evidence for an inter-
action between PABP and a ribosomal protein [21].
Also, the morphological evidence in favor of circular
polysomes may be relevant (see [22] for an example of
this). In this context, it will be interesting to determine
whether translation control occurs independently of the
sequence of the 5' UTR, or whether poly(A)-mediated
control requires upstream sequence elements or secon-
dary structures unique to maternal mRNAs. Second, is
the elaborate system of translational control discussed
here operative only in oocytes and early embryos, or do
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certain somatic cells also take advantage of its regulatory
potential? There are a number of cases in which transla-
tional control is known to be mediated by interactions
of proteins with 3' UTRs [23], but it is not always clear
whether changes in poly(A) tail length may also be in-
volved. The recent rapid progress in the identification of
cis- and trans-acting elements responsible for the dor-
mancy and activation of maternal mRNAs will certainly
help answering these important issues.
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